Comparing Two Medications to Improve Heart Function after Tetralogy of Fallot Surgery
Phase 4
- Conditions
- Health Condition 1: Q213- Tetralogy of Fallot
- Registration Number
- CTRI/2023/07/055845
- Lead Sponsor
- Sree Chitra Tirunal Institute for Medical Sciences and Technology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. All Patients admitted to the cardiac surgery intensive care after corrective cardiac surgery for tetralogy of Fallot will be included in the study
Exclusion Criteria
1. TOF with other congenital cardiac anomalies
2. History of anaphylactic reaction to levosimendan or milrinone
3. Pre-operative renal impairment.
4. Pre-operative hepatic impairment.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method